- Fee assured
- Verified this account
- Benign Prostate disorders
- General urology
- Urological oncology
Ben joined Addenbrooke’s in 2018 as a Consultant Urological and Robotic Surgeon.
Ben sees patients with urinary tract symptoms, such as prostatic symptoms, flow problems, blood in the urine, incontinence, infections or pain. He also happy to see patients with concerns about health issues, such as PSA testing, prostate cancer, bladder cancer, erectile dysfunction, incontinence, testicular lumps, or pain.
Ben trained in general urology in London and the southeast of England. Ben has also undertaken specialist training in prostate, bladder and kidney cancers and robotic surgery, including a Fellowship in urological oncology and robotic surgery at the Peter MacCallum Cancer Centre, Melbourne, Australia.
Alongside his clinical practice Ben is currently lead clinician for urological cancer, and the urology cancer multidisciplinary team (MDT).
Ben also enjoys teaching medical students, doctors and allied healthcare professionals on a wide range of topics from communication skills to MDT working to Urological Sciences. He is course faculty for the Urology MSc at Anglia Ruskin University and the Cambridge Emergency Urology Course; he is also the Male CTA lead for the Cambridge Clinical School.
With his research interest in improving clinical processes, and enjoyment of teaching, Ben has been course director of MDT improvement workshops in England and overseas.
Areas of interest
Prostate cancer; Bladder cancer; PSA testing; Robotic Surgery; LUTS; Lower urinary tract symptoms; Haematuria; Blood in the urine; Chronic Pelvic pain; Testicular pain; Testicular lumps; Erectile Dysfunction; ED
Current NHS consultant posts held
Consultant Urological and Robotic Surgeon,
Cambridge University Hospitals NHS Foundation Trust,
Ben has various interests in research and quality improvement and has published over 100 papers in peer reviewed journals.
For over 10 years Ben has worked with researchers around the world to understand and improve clinical decision making in multidisciplinary cancer teams. He has developed and validated several interventions for cancer teams to use in order to improve their performance, which have been used by researchers and clinicians in different countries and numerous tumour types. Most recently Ben has directed workshops for cancer alliances in England to train lead healthcare professionals to measure and improve decision making in MDT meetings.
Ben is also involved in clinical research and currently sits on the trial management groups for the Cam-PROBE and Neuro-safe studies. He has published research on prostate cancer, PSA testing, bladder cancer, robotic surgery, and enhanced recovery after surgery.
Time with family, growing vegetables in the garden and going to the gym.
2017 The Urology Foundation Longer Term Fellowship Award
2016 Markovitz prize for best trainee. UCLH.
2014 Catherine-Ann Lawrence Literary Excellence Award. Society of Urologic Nurses (SUNA) 45th Annual Conference. Florida.
2005 Distinction in Clinical Sciences at MBBS. University of London
2002 Paul Herbert Steel Scholarship. Peterhouse, University of Cambridge
(Additional) Languages spoken
- Persian (Farsi) - Conversational
Ben's Publications and research interests are listed online at:
Courses offered to GPs
Ben is happy to speak to GPs on a range of urological issues including PSA testing, prostate cancer, bladder cancer, blood in the urine (haematuria), robotic surgery, cancer MDTs, or any of the conditions above.
Outcomes (checked and approved by medical professional body)
Please click on this link if you would like to see information about this healthcare professional’s performance compared to their peers, as published by their medical professional body.https://www.baus.org.uk/patients/surgical_outcomes/default.aspx
Outcomes for Robotic Radical Prostatectomy (as of 08/08/2019):
-Average length of stay: 1 day (95% of patients)
-Transfusion rate: 0.0% (National average 0.7%)
-Overall complication rate: 6.6% (National average 7.2%)
-Positive Surgical Margin rate: 19.5% (National average 26.7%)
-Continence rate (0-1 pad): 80% at 6 weeks post-surgery; 96% at 20 weeks post-surgery
-Nerve sparing (% of cases): Bilateral 44%, Unilateral 37%, None 19%
- FRCS (Urol.) Royal College of Surgeons 2014
- Fellowship in Surgical Oncology Peter MacCallum Cancer Centre 2018
- PhD Imperial College London 2012
- MA University of Cambridge 2006
- MBBS University of London 2005
- Certificate in Robitic Surgery European Robitic Urological Society 2017
Reference number 6130045
Details of entry to specialist register
- Urology, 2017
Affiliations / memberships
British Medical Association
British Association of Urological Surgeons
European Association of Urology
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
Other ways of contacting me
I can be contacted directly using Skype. My Skype ID is: .